Literature DB >> 26870332

Comparison of the effects of melatonin and genistein on radiation-induced nephrotoxicity: Results of an experimental study.

Emine Canyilmaz1, Gonca Hanedan Uslu2, Zumrut Bahat1, Mustafa Kandaz1, Sevdegul Mungan3, Emel Haciislamoglu1, Ahmet Mentese4, Adnan Yoney1.   

Abstract

The aim of the present study was to compare the effects of melatonin and genistein on radiation-induced nephrotoxicity (RIN). A total of 70 Swiss Albino mice were divided into 7 groups. Five control groups were defined, which were sham irradiation (C, G1), radiation therapy only (RT, G2), melatonin (M, G3), genistein (G, G4) and polyethylene glycol-400 (G5), respectively. The co-treatment groups were the RT plus melatonin (RT+M, G6) and RT plus genistein (RT+G, G7) groups. Irradiation was applied using a cobalt-60 teletherapy machine (80-cm fixed source-to-surface distance, 2.5-cm depth). Melatonin was administered (100 mg/kg, intraperitoneal injection) 30 min before the single dose of irradiation, whereas genistein was administered (200 mg/kg, subcutaneous injection) 1 day before the single dose of irradiation. All the mice were sacrificed 6 months after irradiation. As an end point, the extent of renal tubular atrophy for each mouse was quantified with image analysis of histological sections of the kidney. Tissue malondialdehyde (MDA) levels were also measured in each animal. In the histopathological examination of the mouse kidneys, there was a statistically significant reduction (P<0.05) in the presence of tubular atrophy between the RT+M and RT+G groups and the RT group. There was a statistically significant increase in MDA levels in the irradiated versus sham groups (RT vs. C; P<0.05); however, MDA levels were significantly decreased by co-treatment with melatonin or genistein vs. RT alone (RT+M and RT+G vs. RT; P<0.05). In conclusion, the present experimental study showed that melatonin and genistein supplementation prior to irradiation-protected mice against RIN, which may have therapeutic implications for radiation-induced injuries.

Entities:  

Keywords:  genistein; melatonin; mice; nephrotoxicity; radiation; radioprotection

Year:  2015        PMID: 26870332      PMCID: PMC4726846          DOI: 10.3892/br.2015.547

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  56 in total

1.  Genistein mitigates radiation-induced testicular injury.

Authors:  Joong-Sun Kim; Kyu Heo; Joo-Mi Yi; Eun Ji Gong; Kwangmo Yang; Changjong Moon; Sung-Ho Kim
Journal:  Phytother Res       Date:  2011-12-09       Impact factor: 5.878

2.  The histopathologic basis for functional decrements in late radiation injury in diverse organs.

Authors:  D C White
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

3.  [Long-term sequelae in the kidneys following abdominal irradiation of advanced malignant ovarian tumors].

Authors:  W Prager; K Merkelbach
Journal:  Radiobiol Radiother (Berl)       Date:  1986

4.  Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein.

Authors:  Irena Kruk; Hassan Y Aboul-Enein; Teresa Michalska; Krzysztof Lichszteld; Aleksandra Kładna
Journal:  Luminescence       Date:  2005 Mar-Apr       Impact factor: 2.464

5.  The effect of melatonin on eye lens of rats exposed to ultraviolet radiation.

Authors:  M M Anwar; M A Moustafa
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2001-05       Impact factor: 3.228

6.  A simplified radioimmunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man.

Authors:  L Wetterberg; O Eriksson; Y Friberg; B Vangbo
Journal:  Clin Chim Acta       Date:  1978-06       Impact factor: 3.786

7.  Sequential functional testing of radiation-induced renal damage in the mouse.

Authors:  M V Williams; J Denekamp
Journal:  Radiat Res       Date:  1983-05       Impact factor: 2.841

8.  The half-life of melatonin elimination from rat plasma.

Authors:  F P Gibbs; J Vriend
Journal:  Endocrinology       Date:  1981-11       Impact factor: 4.736

9.  Amifostine use in radiation-induced kidney damage. Preclinical evaluation with scintigraphic and histopathologic parameters.

Authors:  Mine Kaldir; Rusen Cosar-Alas; Tevfik Fikret Cermik; Vuslat Yurut-Caloglu; Mert Saynak; Semsi Altaner; Murat Caloglu; Zafer Kocak; Fusun Tokatli; Mevlüt Türe; Sule Parlar; Cem Uzal
Journal:  Strahlenther Onkol       Date:  2008-10-01       Impact factor: 3.621

10.  Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats.

Authors:  Gholamhassan Haddadi; Alireza Shirazi; Zargham Sepehrizadeh; Seied Rabie Mahdavi; Maryam Haddadi
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

View more
  6 in total

Review 1.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

2.  Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury.

Authors:  Filiz Mercantepe; Tolga Mercantepe; Atilla Topcu; Adnan Yılmaz; Levent Tumkaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-02       Impact factor: 3.000

3.  Genistein Ameliorates Ischemia/Reperfusion-Induced Renal Injury in a SIRT1-Dependent Manner.

Authors:  Wei-Fang Li; Kang Yang; Ping Zhu; Hong-Qian Zhao; Yin-Hong Song; Kuan-Can Liu; Wei-Feng Huang
Journal:  Nutrients       Date:  2017-04-20       Impact factor: 5.717

Review 4.  Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects.

Authors:  Qing-Yu Zhang; Fei-Xuan Wang; Ke-Ke Jia; Ling-Dong Kong
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

5.  Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.

Authors:  Yichun Ning; Jing Chen; Yiqin Shi; Nana Song; Xiaofang Yu; Yi Fang; Xiaoqiang Ding
Journal:  Front Pharmacol       Date:  2020-11-19       Impact factor: 5.810

6.  Kidney cell DNA damage caused by combined exposure to volatile anaesthetics and 1 Gy or 2 Gy radiotherapy dose in vivo.

Authors:  Vesna Benković; Nada Oršolić; Anica Horvat Knežević; Nikola Borojević; Gordana Brozović; Mirta Milić
Journal:  Arh Hig Rada Toksikol       Date:  2022-04-07       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.